David Chalmers

Zitiert von

	Alle	Seit 2019
Zitate	3794	1551
h-index	34	20
i10-index	68	45

320

160

240

1996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202412 23 17 26 19 14 21 11 33 38 56 70 71 78 95 116 143 223 205 231 211 244 247 268 272 308 302 300 98

Öffentlicher Zugriff

Alle anzeigen

33 Artikel

9 Artikel

verfügbar

nicht verfügbar

Basierend auf Fördermandaten

Koautoren

Colin PoutonMonash UniversityBestätigte E-Mail-Adresse bei monash.edu
Philip E. ThompsonMedicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash UniversityBestätigte E-Mail-Adresse bei monash.edu
Elizabeth YurievMonash UniversityBestätigte E-Mail-Adresse bei monash.edu
Martin ScanlonProfessor of Medicinal Chemistry, Monash UniversityBestätigte E-Mail-Adresse bei monash.edu
Raymond S. NortonProfessor of Medicinal Chemistry, Monash UniversityBestätigte E-Mail-Adresse bei monash.edu
David ManallackMonash UniversityBestätigte E-Mail-Adresse bei monash.edu
Chris PorterDirector, Monash Institute of Pharmaceutical Sciences, Monash UniversityBestätigte E-Mail-Adresse bei monash.edu
Jerome WielensUniversity of MelbourneBestätigte E-Mail-Adresse bei unimelb.edu.au
Billy Williams-NoonanPost-doctoral Research Fellow, RMIT UniversityBestätigte E-Mail-Adresse bei rmit.edu.au
Keith WatsonWalter & Eliza Hall Institute of Medical ReseachBestätigte E-Mail-Adresse bei wehi.edu.au
Michael W. ParkerSt Vincent's Institute of Medical Research and The University of MelbourneBestätigte E-Mail-Adresse bei svi.edu.au
Jamie SimpsonPuretech HealthBestätigte E-Mail-Adresse bei monash.edu
Trayder ThomasUniversity of ChicagoBestätigte E-Mail-Adresse bei uchicago.edu
Garland R. MarshallProfesso of Biochemistry and Molecular Biophysics, Washington UniversityBestätigte E-Mail-Adresse bei biochem.wustl.edu
Peter ScammellsMonash UniversityBestätigte E-Mail-Adresse bei monash.edu
Tudor OpreaCEO, Expert Systems IncBestätigte E-Mail-Adresse bei expertsystems.inc
Nicholas BarlowMonash UniversityBestätigte E-Mail-Adresse bei monash.edu
Ben CapuanoAssociate Professor in Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, MonashBestätigte E-Mail-Adresse bei monash.edu
Bernard FlynnAssociate ProfessorBestätigte E-Mail-Adresse bei monash.edu
Jo-Anne PinsonRadiopharmaceutical ScientistBestätigte E-Mail-Adresse bei petermac.org

Folgen

David Chalmers

Monash Institute of Pharmaceutical Sciences, Monash University

Bestätigte E-Mail-Adresse bei monash.edu - Startseite

Chemistry Drugs


Titel Nach Zitationen sortieren Nach Jahr sortieren Nach Titel sortieren	Zitiert von Zitiert von	Jahr
Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment I Kufareva, M Rueda, V Katritch, RC Stevens, R Abagyan Structure 19 (8), 1108-1126, 2011	345	2011
The significance of acid/base properties in drug discovery DT Manallack, RJ Prankerd, E Yuriev, TI Oprea, DK Chalmers Chemical Society Reviews 42 (2), 485-496, 2013	313	2013
Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations A Bartholomeusz, BG Tehan, DK Chalmers Antiviral therapy 9 (2), 149-160, 2004	187	2004
Pro-D-NMe-amino acid and D-Pro-NMe-amino acid: simple, efficient reverse-turn constraints DK Chalmers, GR Marshall Journal of the American Chemical Society 117 (22), 5927-5937, 1995	180	1995
Discovery of 7-Hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a Tubulin Polymerization Inhibitor with Potent Antiproliferative … BL Flynn, GS Gill, DW Grobelny, JH Chaplin, D Paul, AF Leske, ... Journal of medicinal chemistry 54 (17), 6014-6027, 2011	164	2011
Free energy methods in drug design: prospects of “alchemical perturbation” in medicinal chemistry: miniperspective BJ Williams-Noonan, E Yuriev, DK Chalmers Journal of medicinal chemistry 61 (3), 638-649, 2018	158	2018
Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen SJF Macdonald, KG Watson, R Cameron, DK Chalmers, DA Demaine, ... Antimicrobial agents and chemotherapy 48 (12), 4542-4549, 2004	117	2004
Molecular dynamics simulations of spontaneous bile salt aggregation DB Warren, DK Chalmers, K Hutchison, W Dang, CW Pouton Colloids and Surfaces A: Physicochemical and Engineering Aspects 280 (1-3 …, 2006	113	2006
Homology modeling and docking evaluation of aminergic G protein-coupled receptors FM McRobb, B Capuano, IT Crosby, DK Chalmers, E Yuriev Journal of chemical information and modeling 50 (4), 626-637, 2010	112	2010
2-Ethoxybenzoxazole as a bioisosteric replacement of an ethyl benzoate group in a human rhinovirus (HRV) capsid binder RN Brown, R Cameron, DK Chalmers, S Hamilton, A Luttick, GY Krippner, ... Bioorganic & medicinal chemistry letters 15 (8), 2051-2055, 2005	86	2005
Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification? J Wielens, SJ Headey, DI Rhodes, RJ Mulder, O Dolezal, JJ Deadman, ... Journal of Biomolecular Screening 18 (2), 147-159, 2013	81	2013
A three-dimensional model of the human immunodeficiency virus type 1 integration complex J Wielens, IT Crosby, DK Chalmers Journal of computer-aided molecular design 19, 301-317, 2005	75	2005
Electrochemical cyclization of dipeptides to form novel bicyclic, reverse-turn peptidomimetics. 2. Synthesis and conformational analysis of 6, 5-bicyclic systems U Slomczynska, DK Chalmers, F Cornille, ML Smythe, DD Beusen, ... The Journal of Organic Chemistry 61 (4), 1198-1204, 1996	70	1996
An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus KG Watson, RN Brown, R Cameron, DK Chalmers, S Hamilton, B Jin, ... Journal of medicinal chemistry 46 (15), 3181-3184, 2003	66	2003
2-Aminothienopyridazines as Novel Adenosine A₁ Receptor Allosteric Modulators and Antagonists GN Ferguson, C Valant, J Horne, H Figler, BL Flynn, J Linden, ... Journal of medicinal chemistry 51 (19), 6165-6172, 2008	63	2008
A chemogenomic analysis of ionization constants—implications for drug discovery DT Manallack, RJ Prankerd, GC Nassta, O Ursu, TI Oprea, DK Chalmers ChemMedChem 8 (2), 242-255, 2013	55	2013
Digestion of phospholipids after secretion of bile into the duodenum changes the phase behavior of bile components WA Birru, DB Warren, A Ibrahim, HD Williams, H Benameur, CJH Porter, ... Molecular pharmaceutics 11 (8), 2825-2834, 2014	54	2014
Cyclosporin structure and permeability: from A to Z and beyond KM Corbett, L Ford, DB Warren, CW Pouton, DK Chalmers Journal of Medicinal Chemistry 64 (18), 13131-13151, 2021	51	2021
Molecular Dynamics of Poly(l-lysine) Dendrimers with Naphthalene Disulfonate Caps BP Roberts, MJ Scanlon, GY Krippner, DK Chalmers Macromolecules 42 (7), 2775-2783, 2009	51	2009
Polymeric precipitation inhibitors promote fenofibrate supersaturation and enhance drug absorption from a type IV lipid-based formulation EJA Suys, DK Chalmers, CW Pouton, CJH Porter Molecular pharmaceutics 15 (6), 2355-2371, 2018	50	2018

Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.

Artikel 1–20

Zitate pro Jahr

Doppelte Zitate

Zusammengeführte Zitate

Koautor hinzufügenKoautoren

Folgen

Zitiert von

Koautoren